<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
    <channel>
                    <title>Men&#039;s health</title>
            <link>https://medicalxpress.com/mens-health-news/</link>
            <language>en-us</language>
            <description>Latest health news and information about Men&#039;s Health</description>

                            <item>
                    <title>The science behind the &#039;man flu&#039;: Zika study adds to mounting evidence for sex-specific immune responses</title>
                    <description>That men tend to suffer more than women when they get sick is an age-old cliché. But a growing body of research suggests that there may be some truth to it. In a new study out of McMaster University, researchers found that biological sex played a significant role in determining the severity of disease following Zika virus infection.</description>
                    <link>https://medicalxpress.com/news/2026-11-science-flu-zika-mounting-evidence.html</link>
                    <category>Men&#039;s health</category>                    <pubDate>Tue, 17 Nov 2026 10:20:08 EST</pubDate>
                    <guid isPermaLink="false">news714131521</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/the-science-behind-the-6.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>What men need to know after a major update to prostate cancer guidelines</title>
                    <description>Middle-aged men should undergo regular screening for prostate cancer, the American Cancer Society said Thursday in a major change to its guidelines.</description>
                    <link>https://medicalxpress.com/news/2026-11-men-major-prostate-cancer-guidelines.html</link>
                    <category>Men&#039;s health</category>                    <pubDate>Fri, 13 Nov 2026 05:00:04 EST</pubDate>
                    <guid isPermaLink="false">news713765862</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/prostate-cancer-screen.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>New guidelines recommend regular prostate cancer screening for all middle-aged men</title>
                    <description>Experts now recommend regular prostate cancer screening for all men ages 50 to 69 and earlier for higher-risk groups, according to new American Cancer Society (ACS) guidelines.</description>
                    <link>https://medicalxpress.com/news/2026-11-guidelines-regular-prostate-cancer-screening.html</link>
                    <category>Men&#039;s health</category>                    <pubDate>Thu, 12 Nov 2026 13:20:15 EST</pubDate>
                    <guid isPermaLink="false">news713707416</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/man-at-doctors-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>A blood test could help identify men with advanced prostate cancer most likely to benefit from targeted radiotherapy</title>
                    <description>A blood test could help identify men with advanced prostate cancer who are more likely to experience longer disease control following targeted radiotherapy, according to research led by The Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, London and University College London. The findings are published in the journal JAMA Network Open.</description>
                    <link>https://medicalxpress.com/news/2026-11-blood-men-advanced-prostate-cancer.html</link>
                    <category>Men&#039;s health</category>                    <pubDate>Thu, 12 Nov 2026 04:00:01 EST</pubDate>
                    <guid isPermaLink="false">news713678292</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/a-blood-test-could-hel.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Prostate cancer drug combination adds toxicity without clear benefit for tumors lacking targetable mutations</title>
                    <description>The prospective, multicenter, randomized phase 2 ZZ-FIRST clinical trial, led by the Vall d&#039;Hebron Institute of Oncology&#039;s (VHIO) Prostate Cancer Group, evaluated the androgen receptor pathway inhibitor (ARPI) enzalutamide plus the poly(ADP-ribose) polymerase inhibitor (PARPi) talazoparib versus enzalutamide alone in patients with high-tumor-burden metastatic prostate cancer who had not previously received hormone therapy.</description>
                    <link>https://medicalxpress.com/news/2026-11-prostate-cancer-drug-combination-toxicity.html</link>
                    <category>Men&#039;s health</category>                    <pubDate>Tue, 10 Nov 2026 17:20:08 EST</pubDate>
                    <guid isPermaLink="false">news713545981</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/prostate-cancer-drug-c.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Immune proteins offer new clues to how prostate cancer could be prevented</title>
                    <description>A new study led by researchers at Oxford Population Health shows that higher levels of proteins involved in activating and coordinating the immune system were associated with a lower risk of developing prostate cancer. The findings suggest that the body&#039;s ability to recognize and respond to abnormal cells may play an important role in the early development of prostate cancer and could point to new approaches for preventing the disease.</description>
                    <link>https://medicalxpress.com/news/2026-11-immune-proteins-clues-prostate-cancer.html</link>
                    <category>Men&#039;s health</category>                    <pubDate>Tue, 10 Nov 2026 05:00:01 EST</pubDate>
                    <guid isPermaLink="false">news713449204</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/blood-test-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>&#039;Looksmaxxing&#039; can include starvation, steroids and deliberate blows to the face</title>
                    <description>A rapidly growing online trend known as &quot;looksmaxxing&quot; may expose some boys and young men to significant physical and mental health risks, according to a new commentary published in the Journal of Adolescent Health.</description>
                    <link>https://medicalxpress.com/news/2026-11-looksmaxxing-starvation-steroids-deliberate.html</link>
                    <category>Psychology &amp; Mental health</category>                    <pubDate>Mon, 09 Nov 2026 15:20:04 EST</pubDate>
                    <guid isPermaLink="false">news713453403</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/teen-boy-mirror.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Why obesity affects males and females differently</title>
                    <description>University of California, Riverside, scientists have an explanation for why males and females respond differently to obesity. They report in PNAS Nexus that certain immune cell populations in fat tissue may protect against obesity-related inflammation while others may contribute to harmful metabolic changes. They found these immune cells, called eosinophils and traditionally associated with asthma and allergies, behave differently in males and females.</description>
                    <link>https://medicalxpress.com/news/2026-11-obesity-affects-males-females-differently.html</link>
                    <category>Weight management</category>                    <pubDate>Mon, 09 Nov 2026 09:40:06 EST</pubDate>
                    <guid isPermaLink="false">news713439001</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/overweight-people.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>New study identifies biological mechanism driving therapy resistance in advanced prostate cancer</title>
                    <description>A multi-institutional collaborative study led by researchers at the University of Chicago and the Fred Hutchinson Cancer Center has identified a previously unknown biological mechanism that controls cell identity and treatment resistance in advanced prostate cancer.</description>
                    <link>https://medicalxpress.com/news/2026-11-biological-mechanism-therapy-resistance-advanced.html</link>
                    <category>Men&#039;s health</category>                    <pubDate>Sat, 07 Nov 2026 08:00:06 EST</pubDate>
                    <guid isPermaLink="false">news712835726</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/prostate-cancer.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Prostate cancer drug shows promise in new clinical trial</title>
                    <description>In a recent Yale-led clinical trial, a new type of prostate cancer drug showed promising results in reducing tumor activity and pain for patients with metastatic prostate cancer.</description>
                    <link>https://medicalxpress.com/news/2026-11-prostate-cancer-drug-clinical-trial.html</link>
                    <category>Men&#039;s health</category>                    <pubDate>Wed, 04 Nov 2026 10:40:20 EST</pubDate>
                    <guid isPermaLink="false">news713008659</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/prostate-cancer-drug-s.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Researchers identify critical window for boosting immunotherapy response in prostate cancer</title>
                    <description>Researchers at Roswell Park Comprehensive Cancer Center have shown that hormone-blocking therapies commonly used to treat prostate cancers temporarily activate the body&#039;s immune response before those immune effects begin to fade over time. In a new publication in the Journal for Immunotherapy of Cancer, a team led by Kent Nastiuk, Ph.D., reports this discovery—and points the way to a treatment strategy for taking advantage of this window of opportunity.</description>
                    <link>https://medicalxpress.com/news/2026-10-critical-window-boosting-immunotherapy-response.html</link>
                    <category>Men&#039;s health</category>                    <pubDate>Thu, 29 Oct 2026 08:20:25 EDT</pubDate>
                    <guid isPermaLink="false">news712480025</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/researchers-identify-c-8.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Diagnostic test could help doctors refine prostate cancer treatment</title>
                    <description>Prostate cancer is the most common cancer in men—in 2013, it affected more than 1 million men across the world. The cancer does not behave the same way in every patient, and doctors have long faced a difficult balancing act between identifying patients who will benefit from more intensive treatment and those who may do just as well without it. Treating someone more aggressively than necessary is associated with increased side effects and poorer quality of life.</description>
                    <link>https://medicalxpress.com/news/2026-10-diagnostic-doctors-refine-prostate-cancer.html</link>
                    <category>Men&#039;s health</category>                    <pubDate>Fri, 23 Oct 2026 20:40:01 EDT</pubDate>
                    <guid isPermaLink="false">news711972301</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/genomic-test.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>STI rates drop following antibiotic use recommendations for gay and bisexual men</title>
                    <description>After years of rising sexually transmitted infection (STI) rates in Australia, new Burnet Institute–led research has found promising evidence that an existing antibiotic taken after sex may be helping to reduce syphilis and chlamydia diagnoses among gay and bisexual men.</description>
                    <link>https://medicalxpress.com/news/2026-10-sti-antibiotic-gay-bisexual-men.html</link>
                    <category>Common illnesses &amp; Prevention</category>                    <pubDate>Wed, 21 Oct 2026 15:20:07 EDT</pubDate>
                    <guid isPermaLink="false">news711806202</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/sti-rates-drop-followi.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Blood proteins could reveal clues to prostate cancer risk more than a decade before diagnosis</title>
                    <description>Proteins linked to the immune system, cell adhesion, blood vessel formation and known prostate cancer genes were associated with the future risk of developing prostate cancer, including aggressive disease, in a new study led by researchers at Oxford Population Health.</description>
                    <link>https://medicalxpress.com/news/2026-10-blood-proteins-reveal-clues-prostate.html</link>
                    <category>Men&#039;s health</category>                    <pubDate>Wed, 21 Oct 2026 14:30:01 EDT</pubDate>
                    <guid isPermaLink="false">news711792961</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2018/bloodsample.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Genomic cancer driver study reveals new clues to why some prostate cancers become aggressive</title>
                    <description>Why do some prostate cancers grow slowly for years, while others progress quickly to life-threatening metastatic disease? An international team of researchers co-led by the Ontario Institute for Cancer Research (OICR) and the University of Copenhagen has uncovered new clues in the genomes of prostate cancers.</description>
                    <link>https://medicalxpress.com/news/2026-10-genomic-cancer-driver-reveals-clues.html</link>
                    <category>Men&#039;s health</category>                    <pubDate>Fri, 16 Oct 2026 16:20:09 EDT</pubDate>
                    <guid isPermaLink="false">news711376921</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/genomic-cancer-driver.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Targeted radioactive therapy may help delay spread of recurrent prostate cancer</title>
                    <description>Adding the targeted radioactive drug 177Lu-PNT2002 to stereotactic body radiation therapy, or SBRT, may help keep recurrent prostate cancer under control longer than SBRT alone, according to new research led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center.</description>
                    <link>https://medicalxpress.com/news/2026-10-radioactive-therapy-delay-recurrent-prostate.html</link>
                    <category>Men&#039;s health</category>                    <pubDate>Tue, 13 Oct 2026 11:40:31 EDT</pubDate>
                    <guid isPermaLink="false">news711108050</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/radioactive-therapy.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Low-risk prostate tumors reveal molecular signs linked to more aggressive cancer</title>
                    <description>A new study revealed molecular features linked to more aggressive prostate cancer in a subset of patients who had been classified as low risk, highlighting biological differences that may not be apparent from clinical measures alone. The results could lead to new therapeutic strategies.</description>
                    <link>https://medicalxpress.com/news/2026-10-prostate-tumors-reveal-molecular-linked.html</link>
                    <category>Men&#039;s health</category>                    <pubDate>Wed, 07 Oct 2026 16:40:06 EDT</pubDate>
                    <guid isPermaLink="false">news710605686</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/low-risk-prostate-tumo.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Key driver of aggressive prostate cancer identified, suggesting new way to reverse drug resistance</title>
                    <description>Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine whether prostate tumors remain sensitive to treatment or evolve into a more aggressive, drug-resistant form of the disease.</description>
                    <link>https://medicalxpress.com/news/2026-10-key-driver-aggressive-prostate-cancer.html</link>
                    <category>Men&#039;s health</category>                    <pubDate>Wed, 07 Oct 2026 11:00:02 EDT</pubDate>
                    <guid isPermaLink="false">news710522401</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/key-driver-of-aggressi.jpg" width="90" height="90" />
                                    </item>
                        </channel>
</rss>